Search | Search by Center | Search by Source | Keywords in Title
Gregg LP, Richardson PA, Nambi V, Petersen LA, Matheny ME, Virani SS, Navaneethan SD. Sodium-Glucose Cotransporter-2 Inhibitor and Glucagon-Like Peptide-1 Receptor Agonist Discontinuation in Patients with CKD. Journal of the American Society of Nephrology : JASN. 2024 Aug 26.